Table I.
Clinical and demographic characteristics of patients.
| Characteristics | Patient no. (%) (n=142) | |
|---|---|---|
| Age (years) | ||
| <5 | 58 | (40.8) |
| 5–10 | 65 | (45.8) |
| >10 | 19 | (13.4) |
| Gender | ||
| Female | 52 | (36.6) |
| Male | 90 | (63.4) |
| Residence | ||
| Rural | 89 | (62.7) |
| Urban | 53 | (37.3) |
| Consanguinity | ||
| Positive | 33 | (23.2) |
| Negative | 109 | (76.8) |
| Histological type | ||
| Burkitt's lymphoma | 98 | (69.0) |
| Lymphoblastic lymphoma | 26 | (18.3) |
| Large-cell lymphoma | 15 | (10.6) |
| Anaplastic large-cell lymphoma | 3 | (2.1) |
| Primary site | ||
| Abdomen | 104 | (73.2) |
| Mediastinum | 23 | (16.2) |
| Peripheral lymph nodes | 9 | (6.4) |
| Other | 6 | (4.2) |
| Stage | ||
| I | 2 | (1.4) |
| II | 14 | (9.9) |
| III | 95 | (66.9) |
| IV | 31 | (21.8) |
| LDH (IU/dl) | ||
| ≤500 | 41 | (28.9) |
| >500 | 101 | (71.1) |
| Protocol | ||
| LMB-96 | 113 | (79.6) |
| CCG-1961 | 26 | (18.3) |
| BFM-NHL 90 | 3 | (2.1) |
| Outcome | ||
| Alive in CR | 120 | (84.5) |
| Alive following relapse | 6 | (4.2) |
| Deceased | 16 | (11.3) |
LDH, lactate dehydrogenase; CR, complete remission.